Health-Related Quality of Life in Patients with Chronic Myeloid Leukemia Treated with First- Versus Second-Generation Tyrosine Kinase Inhibitors

The life expectancy of patients with chronic myeloid leukemia (CML) approaches that of the age-matched population and quality of life (QOL) issues are becoming increasingly important. To describe patients’ characteristics and assess QOL, we delivered a 30-item core questionnaire, a 24-item CML-speci...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Shacham Abulafia, Adi, Shemesh, Sivan, Rosenmann, Lena, Berger, Tamar, Leader, Avi, Sharf, Giora, Raanani, Pia, Rozovski, Uri
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692789/
https://ncbi.nlm.nih.gov/pubmed/33113857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113417
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars